PARK AVENUE SECURITIES LLC
Broker-DealerPosition in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1071640
NEW YORK, NY
Position in KNSA
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$942,239
New position
Shares Held
14,734
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#130
of 264 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $5,937,881 across 8 Drug Manufacturers - Specialty & Generic names. KNSA ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
8,601 | $1,449,612 | |
| 2 | HLN |
Haleon plc
|
111,923 | $1,044,241 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
14,734 | $942,239 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
44,827 | $718,576 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,191 | $650,191 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,038 | $562,419 | |
| 7 | ZTS |
Zoetis Inc.
|
4,994 | $358,868 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
12,232 | $211,735 |
All Filings in KNSA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $942,239 | 14,734 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||